Tackling vascular risk factors as a possible disease modifying intervention in Parkinson’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Tackling vascular risk factors as a possible disease modifying intervention in Parkinson’s disease ; volume:10 ; number:1 ; day:2 ; month:3 ; year:2024 ; pages:1-4 ; date:12.2024
npj Parkinson's Disease ; 10, Heft 1 (2.3.2024), 1-4, 12.2024
- Urheber
-
Visser, Anne E.
Vries, Nienke M. de
Richard, Edo
Bloem, Bastiaan R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-024-00666-6
- URN
-
urn:nbn:de:101:1-2405071031134.242084780073
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Visser, Anne E.
- Vries, Nienke M. de
- Richard, Edo
- Bloem, Bastiaan R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link
Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
npj Parkinson's Disease
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics
Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease
Molecular pathways to Parkinson’s disease
Genetic Architecture of Parkinson’s Disease
Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link
Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
npj Parkinson's Disease
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics
Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease
Molecular pathways to Parkinson’s disease
Genetic Architecture of Parkinson’s Disease
Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link
Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
npj Parkinson's Disease
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics
Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease
Molecular pathways to Parkinson’s disease